Patents/Assignees

Urovant Sciences GmbH

2 patents in portfolio

US12357636utility2025
Vibegron for the Treatment of Overactive Bladder Symptoms
0 cites
US12102638utility2024
Use of Vibegron to Treat Overactive Bladder
0 cites